Delivery Order SPE2DB20D1050-SPE2DB25FH52M

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of IMBRUVICA 420 MG TABLET 28S. The award, valued at $7,575.75, is a firm fixed-price contract with a completion date of December 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $7,322.67 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to military...
This is a $7,322.67 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for 4,564,522,930 units of the pharmaceutical product IMBRUVICA 420 MG Tablet 28S. The contract has a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,151.52 firm-fixed-price delivery order is for IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product. The contract has a period of performance through February 6, 2025 and was awarded on January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules, a specialty medication used for various medical treatments. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,116.87 firm fixed-price delivery order is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order is for the supply of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH52M
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order is for IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors. The DLA is the funding agency, and this contract supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 6/5/25, 10:20 AM